Stock info Mesa Laboratories | Filter  Basic-Info

Mesa Laboratories

The past year gave good returns for Mesa Laboratories investors

The period between December 2015 and December 2016 was a profitable period for the investors in Mesa Laboratories. The stock gained around 26 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 214 percent. Mesa Laboratories's revenues between 2011 and 2015 were far from constant and moved between 39,62 million dollars and 71,33 million dollars. During 2011 and 2015 Mesa Laboratories's net results were very volatile and fluctuated between 6,18 million dollars and 9,58 million dollars.

Mesa Laboratories is active in the health care eq. & services sector. The global health care companies gained around 102 percent over the last 10 years. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

The American company paid out dividends in the past 5 years. Mesa Laboratories's dividend return over the period 2011 - 2015 was around 2,7 percent per year.

Mesa Laboratories financed with a quite low debt position

At the end of 2015 the health care company's balance sheet equaled 117,32 million dollars. The total debt of the health care company was at the end of 2015 43,84 million dollars, which equals around 37,37 percent of the total balance sheet. As per the end of 2015 Mesa Laboratories's price/earnings-ratio equaled 28. So investors paid for 1 stock 28 times the earnings per share of 2015. Based on the classical stock valuation theories the American stock can be seen as a growth stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the health care company equaled around 364,18 million dollars. At the end of 2015 around 3,52 million stocks were listed.

All the company's financial reports are available here. More information about Mesa Laboratories can be found it's website. .